Live feed
Filing
SC 13D/A
SC 13D/A0001193125-24-155898·Frazier Life Sciences Public Fund, L.P.
Schedule 13D ownership disclosure
Phathom Pharmaceuticals Inc
Security class unavailable · CUSIP: 71722W107
Event date: 2024-03-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-155898
- Form type
- SC 13D/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Jun 06, 2024
- Reporting period
- Mar 07, 2024
- Description
- Schedule 13D beneficial ownership